Clinical Roundup NCCN updates CML treatment guidelines following FDA approval of Scemblix for newly diagnosed patients November 22, 2024Vol.50 No.44
Clinical Roundup American Lung Association’s “State of Lung Cancer” report points to stark differences in survival, screening and treatment across states November 22, 2024Vol.50 No.44
Clinical Roundup Phase III trial of subcutaneous pembrolizumab with berahyaluronidase alfa meets primary endpoints November 22, 2024Vol.50 No.44
Clinical Roundup Exact Sciences data show multi-biomarker class approach improves MCED cancer detection November 22, 2024Vol.50 No.44
Clinical Roundup Mushroom supplement may slow prostate cancer progression, City of Hope study finds November 22, 2024Vol.50 No.44
Clinical Roundup Nivolumab + epigenetic drug induce immune response in some resistant pancreatic cancers November 22, 2024Vol.50 No.44
Clinical Roundup Remote telemedicine tool found highly accurate in diagnosing melanoma November 22, 2024Vol.50 No.44
Clinical Roundup UVA Health tests focused ultrasound to increase immune response in melanoma November 22, 2024Vol.50 No.44
Clinical Roundup Model created by Cedars-Sinai investigators could speed patient selection for clinical trials November 22, 2024Vol.50 No.44
